The pharmaceutical industry in 2025: Trends that remain unchanged

2025 has so far been a year of fast changes. While emerging technologies like AI and robotics dominate headlines, several trends from previous years remain just as impactful. It is essential for the pharma industry to move forward with upcoming technologies.

Mentioned below are the key pharmaceutical trends 2025 that are shaping the industry: -

1. Site-of-care shifts accelerate and globalize

While site-of-care shifts are popular in 2025, ambulatory surgery centers (ASCs) are becoming relevant, especially for joint replacement surgeries. Most patients prefer these places as they are less complicated and feel more comfortable. Hospitals, on the other hand, are noticing they are losing some profitable surgeries and are starting to build their ASCs or work with doctors in new ways.

2. Robotic surgery and sticky implants

Robotic surgeries are now being used in ASCs. However, the adoption of robotics in surgery is making it difficult for new companies to enter the market as surgeons get used to certain robots and implants. Robots and the implants doctors use become sticky, which means they dont want to switch to something else once they are used to them.

3. Pharmaceutical breakthroughs reshape surgical approaches

New drugs, like those for weight loss (GLP-1s), are getting a lot of attention. However, their biggest impact is on bariatric surgery. On the other hand, oncology is improving a lot. Doctors are finding cancer earlier and using better, more targeted therapies. This means a growing demand for diagnostics but fewer major reconstructions, highlighting the importance of oncology consulting services to navigate this evolving industry.

4. AI sorting continues, but not just for products

Most AI applications are for diagnosing diseases, especially in radiology and cardiology. However, making money from these applications is difficult, and they will continue to struggle to find value unless they provide operational efficiencies. While AI in products is exciting, the real value is in using AI to optimize operations, which will drive value.

ASC strategies, sticky technologies, and AI will define success in the pharmaceutical industry. Thus, pharma industry leaders must ensure that innovation translates into tangible value for providers, patients, and stakeholders.